ASSEMBLY BIOSCIENCES, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $72.3 | $28.5 | $7.2 | $0.0 | $6.3 |
| Operating income | -$12.1 | -$45.4 | -$64.6 | -$94.1 | -$132.7 |
| Net income | -$6.1 | -$40.2 | -$61.2 | -$93.1 | -$129.9 |
| Cash Flow Statement | |||||
| Free cash flow | -$41.2 | -$51.1 | $22.5 | -$84.6 | -$96.5 |
Shares outstanding 20.4M · Free float 34.3%
Annual filing data through FY ended December 31, 2025; float as of September 19, 2026.